Filing Flows › Fortress Biotech (FBIO) › Q1 2026 › vs Q4 2025
Fortress Biotech (FBIO) Q1 2026 vs Q4 2025 (quarter over quarter)
Fortress Biotech's revenue fell $41K (-0.3%) from $16.1M in Q4 2025 to $16.0M in Q1 2026.
Fortress Biotech, Q1 2026: revenue $16.0M (+22% year over year), operating margin -48.3%, net earnings $137M, operating cash flow $204M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $16.0M | $16.1M | −$41K | -0.3% |
| Other income, net | $150M | −$1.4M | $151M | — |
| Costs & expenses | $166M | $22.3M | $144M | +645% |
| Operating costs | $23.8M | $20.9M | $2.9M | +14% |
| Income tax | $5.1M | −$816K | $5.9M | — |
| Net earnings | $137M | −$5.4M | $143M | — |
| Cost of revenue | $6.2M | $5.4M | $778K | +14% |
| SG&A | $15.9M | $14.7M | $1.2M | +8% |
| Other operating costs | $1.1M | $698K | $428K | +61% |
| Operating cash sources | $204M | −$12.5M | $216M | — |
| Depreciation & amortization | $1.2M | $1.2M | $62K | +5% |
| Share-based compensation | $1.8M | $2.5M | −$703K | -29% |
| Working capital & other | $63.7M | −$10.8M | $74.5M | — |
| Operating cash flow | $204M | −$12.5M | $216M | — |
Questions
How much did Fortress Biotech's revenue grow quarter over quarter in Q1 2026?
Fortress Biotech's revenue fell $41K (-0.3%) from $16.1M in Q4 2025 to $16.0M in Q1 2026.